According to BELLUS Health's latest financial reports the company's current earnings (TTM) are -$86.65 M. In 2022 the company made an earning of -$75.95 M a decrease over its 2021 earnings that were of -$71.37 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$86.65 M | 14.1% |
2022 | -$75.95 M | 6.41% |
2021 | -$71.37 M | 125.01% |
2020 | -$31.72 M | 58.08% |
2019 | -$20.07 M | 295.42% |
2018 | -$5.08 M | 259.51% |
2017 | -$1.42 M | 12.04% |
2016 | -$1.26 M | -947.63% |
2015 | $0.14 M | -109.57% |
2014 | -$1.56 M | 114.77% |
2013 | -$0.73 M | |
2010 | -$14.19 M | 147.4% |
2009 | -$5.74 M | -87.12% |
2008 | -$44.5 M | -32.35% |
2007 | -$65.78 M | 15.26% |
2006 | -$57.07 M | 7.35% |
2005 | -$53.17 M | 53.76% |
2004 | -$34.58 M | |
2002 | -$8.66 M | 307.23% |
2001 | -$2.13 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | 27.85% | ๐บ๐ธ USA |